Looks like things are about to get interesting in Surgical Urology too
Surgical Urology
- Thread starter Anonymous
- Start date
-
- Tags
- None
Easy Robinson, we know your exceptionally low quota and sandbagging were successful again this year.
Why don't you get off your butt and get some new business. We have the best products.
Growing a 2.2M territory 7+% is more difficult and requires significantly more cases than your 1.2M territory. I hope you enjoyed your last year of cruise control commission windfalls. You've been exposed
Meeting sucked but as usual the coloplast women were on the prowl and willing. I dont know what it is about being away from their husband that makes women sleezy. Just like a frat party.
Who threw down on the 10 cm NB? (I presume that's all the guys in our company are packing)
By "our company" you mean BSX/AMS/POS you would be right. Get your sizes right Troll.
The only chance you'll have to stand out in a positive way is if we send you to Asia on the next skw trip
Does it really matter? If people think a change is benefitial then go for it. The product is ehh, not great not bad either probably less invasive than a turp or laser turp. The big selling point is guy can still cum on the faces of their side pieces and what 70 year old guy not named Jack Nicolson doesnt do this with regularity? Those who left will be board in 6 months. Oh yeah if you cant sell clinically and create a finance story, which is about 100% of those who left you will be in for a treat.
Urologist will be hiring another staff person to make collection calls because Abe failed to pay for his 2nd and 3rd set of staples. Have fun when the docs cannot recoup the cost of the staples.
Funny but true. With turp and laser upon climax the mans seed shoots back into the bladder and not on "his side piece face.." so those who want to dress up their partner will be more statisfied with urolift since they can see their finished art work when done. Dotting the eyes is what the kids call it today.
Holy hell, your grammar and mechanics are atrocious. I'm going to assume you're either a high school dropout or a meathead troll from Boston Scientific.
Regarding the exodus to Neotract, the individuals who defected were among the best sales reps I've met during my career. The product has gained positive reviews from customers, it has a solid foundation of early clinical support, and the primary barrier to trial/adoption will be overcome in the near term (coverage).
One might suspect your perspective and judgement has been clouded by the taste of sour grapes (i.e., you not receiving an offer to join the Neotract crew).
Barrier to adoption is not a lack of coverage. It has coverage and coding. the primary issue is docs dont want to stock this and they all know that they will need more than 3 staples to control the growth of the prostate. 4 or more and the doc then has to charge the patient, its like offering to buy 1/2 a turp. Secondly, insurers are forcing docs to due traditional surgery, turp, button or laser turp FIRST line becuase of a lack of data for urolift. Does it work? Yes. Its a great product for younger men who are older than 50 and still want to dump their seed outside of their own bodies. Those who left COLO are in for a harsh reality when they think that simply because they could sell an inflatable cock implant that they can sell bph procedure.
Your information is inaccurate. Although codes have been created, coverage decisions are still in progress. Medicare coverage, for instance, is determined regionally by committees which only meet a handful of times each year. Commercial insurers generally mirror Medicare with respect to coding, coverage, and reimbursement policy. Long story short, they'll eventually get favorable coverage.
Regarding your narrowly defined patient target segment, it's a safe bet that you're underestimating the market for a minimally- or essentially non-invasive permanent treatment intervention that can be delivered in-office.
For Coloplasters, I'd be more concerned that the overwhelming majority of division revenue (and therefore your livelihood) relies on a product that will face coverage pressure and decreasing consumer demand. Employers trying to reduce health care costs will select plans that exclude IPP coverage and/or shift a greater portion of costs to the patient in the form of higher deductibles and co-payments. On net, implant volume might be flat or even decline year-over-year.
Those who left Coloplast were wise to jump off a sinking ship.
Eventually. But those who left think neo is a great opportunity because the've had success selling inflatable cock pieces to a very very very narrow space of the uro market. These people will be in for a wake up call when they realized that urolift is positioned after waiting, meds, more meds, traditional surgery and then its time to try urolift. The sweet spot of the market are not the medicare patients its the guys less than 65 and older than 50. These guys want to fuck and this is exactly to whom neotract is marketing to.
The market is everyone who gets turp, tuna, tuip, buttons, laser, holep, meds, etc. The potential is millions of patients its 90% of all men after age 80 they have BPH. The reality is a tiny fraction will want to pay thousands out of pocket for urolift, unless they are younger men who still want to bust nuts.
The colo people who left are in for a shock one that will impact their wallet or purse. The grass aint greener.